Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VTYX |
---|---|---|
09:32 ET | 15291 | 2.115 |
09:34 ET | 4789 | 2.1 |
09:36 ET | 861 | 2.11 |
09:38 ET | 1507 | 2.114 |
09:39 ET | 375 | 2.11 |
09:41 ET | 4045 | 2.12 |
09:45 ET | 100 | 2.135 |
09:48 ET | 6732 | 2.12 |
09:50 ET | 11747 | 2.09 |
09:52 ET | 22047 | 2.08 |
09:54 ET | 2788 | 2.08 |
09:56 ET | 14829 | 2.085 |
09:57 ET | 1937 | 2.09 |
09:59 ET | 2100 | 2.11 |
10:01 ET | 4152 | 2.13 |
10:03 ET | 962 | 2.13 |
10:06 ET | 6863 | 2.12 |
10:08 ET | 1500 | 2.11 |
10:10 ET | 261 | 2.11 |
10:12 ET | 800 | 2.13 |
10:14 ET | 1090 | 2.17 |
10:15 ET | 629 | 2.18 |
10:17 ET | 2375 | 2.2 |
10:19 ET | 5143 | 2.21 |
10:21 ET | 1118 | 2.22 |
10:24 ET | 10515 | 2.23 |
10:26 ET | 1130 | 2.23 |
10:28 ET | 4628 | 2.24 |
10:30 ET | 29472 | 2.23 |
10:32 ET | 300 | 2.235 |
10:33 ET | 451 | 2.24 |
10:35 ET | 24628 | 2.235 |
10:37 ET | 33556 | 2.215 |
10:39 ET | 2661 | 2.215 |
10:42 ET | 100 | 2.215 |
10:44 ET | 9064 | 2.23 |
10:46 ET | 2690 | 2.2227 |
10:48 ET | 4498 | 2.24 |
10:50 ET | 2300 | 2.2492 |
10:51 ET | 500 | 2.245 |
10:53 ET | 300 | 2.245 |
10:55 ET | 24576 | 2.245 |
10:57 ET | 11766 | 2.23 |
11:00 ET | 4404 | 2.22 |
11:02 ET | 1000 | 2.22 |
11:04 ET | 800 | 2.22 |
11:06 ET | 1100 | 2.225 |
11:08 ET | 1900 | 2.225 |
11:09 ET | 1000 | 2.225 |
11:11 ET | 2633 | 2.23 |
11:13 ET | 2043 | 2.25 |
11:15 ET | 7557 | 2.25 |
11:18 ET | 2911 | 2.25 |
11:20 ET | 1500 | 2.245 |
11:22 ET | 5197 | 2.2408 |
11:24 ET | 200 | 2.245 |
11:26 ET | 66344 | 2.255 |
11:27 ET | 2599 | 2.255 |
11:29 ET | 500 | 2.25 |
11:31 ET | 2184 | 2.2425 |
11:33 ET | 11696 | 2.225 |
11:36 ET | 1849 | 2.2292 |
11:38 ET | 3420 | 2.23 |
11:40 ET | 300 | 2.235 |
11:42 ET | 500 | 2.235 |
11:44 ET | 3568 | 2.23 |
11:45 ET | 604 | 2.22 |
11:51 ET | 1150 | 2.24 |
11:54 ET | 300 | 2.25 |
11:56 ET | 300 | 2.24 |
11:58 ET | 200 | 2.24 |
12:00 ET | 1305 | 2.245 |
12:02 ET | 2689 | 2.25 |
12:03 ET | 100 | 2.25 |
12:05 ET | 5595 | 2.25 |
12:07 ET | 5508 | 2.245 |
12:09 ET | 4730 | 2.245 |
12:12 ET | 1021 | 2.235 |
12:14 ET | 38536 | 2.2125 |
12:16 ET | 1250 | 2.21 |
12:18 ET | 16416 | 2.195 |
12:20 ET | 400 | 2.195 |
12:21 ET | 4100 | 2.195 |
12:23 ET | 1000 | 2.21 |
12:25 ET | 300 | 2.21 |
12:27 ET | 100 | 2.21 |
12:30 ET | 246 | 2.22 |
12:32 ET | 300 | 2.215 |
12:34 ET | 1123 | 2.22 |
12:36 ET | 3954 | 2.225 |
12:38 ET | 1691 | 2.24 |
12:39 ET | 900 | 2.24 |
12:41 ET | 4946 | 2.23 |
12:43 ET | 1133 | 2.22 |
12:45 ET | 500 | 2.225 |
12:48 ET | 1600 | 2.225 |
12:50 ET | 14651 | 2.225 |
12:52 ET | 4079 | 2.22 |
12:54 ET | 4942 | 2.22 |
12:56 ET | 11366 | 2.21 |
12:57 ET | 5543 | 2.21 |
12:59 ET | 12449 | 2.22 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ventyx Biosciences Inc | 150.9M | -0.7x | --- |
Vigil Neuroscience Inc | 150.5M | -1.9x | --- |
Elevation Oncology Inc | 153.0M | -2.6x | --- |
Atossa Therapeutics Inc | 145.9M | -5.0x | --- |
Achieve Life Sciences Inc | 157.6M | -3.5x | --- |
Yubo International Biotech Ltd | 154.6M | -19.1x | --- |
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $150.9M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.24 |
Book Value | $4.12 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.